Key result
Peguero-Lo Presti criterion achieves highest discrimination for detecting LVH with ~0.68 AUC.
Why the study?
Electrocardiography is widely used to screen for left ventricular hypertrophy, but its diagnostic performance varies across criteria.
How accurately do four electrocardiographic criteria (Cornell Product, Sokolow-Lyon, Romhilt-Estes, and Peguero-Lo Presti) detect echocardiographic left ventricular hypertrophy in adults with uncomplicated hypertension?
Cross-Sectional (n=150)
How accurately do four electrocardiographic criteria (Cornell Product, Sokolow-Lyon, Romhilt-Estes, and Peguero-Lo Presti) detect echocardiographic left ventricular hypertrophy in adults with uncomplicated hypertension?
In adults with uncomplicated hypertension, standard ECG criteria have high specificity but low sensitivity and only modest overall discrimination for detecting LVH, underscoring the need for echocardiography for definitive diagnosis.
Answers are grounded in this paper and cite their sources.
ECG criteria should not replace echocardiography for LVH detection in hypertension; leaves open whether refined thresholds improve utility in prospective cohorts.
Electrocardiography (ECG) is widely used to screen for left ventricular hypertrophy (LVH), but its diagnostic performance varies across criteria. This cross-sectional diagnostic accuracy study compared the Cornell Product, Sokolow–Lyon, Romhilt–Estes, and Peguero–Lo Presti criteria against transthoracic echocardiography in 150 adults with uncomplicated hypertension. Left ventricular geometry was classified according to American Society of Echocardiography recommendations, and diagnostic performance was assessed using sensitivity, specificity, predictive values, and receiver operating characteristic (ROC) analysis with 95% confidence intervals (CIs). Concentric hypertrophy was the predominant pattern (51.3%). Only Romhilt–Estes and Sokolow–Lyon were significantly associated with echocardiographic LVH (p < 0.001 and p = 0.023). At conventional thresholds, all criteria showed low sensitivity (12.9%–33.3%) but high specificity (84.2%–94.7%). In ROC analysis, Peguero–Lo Presti achieved the highest, albeit modest, discrimination (AUC 0.680, 95% CI 0.566–0.793; sensitivity 78.8%), whereas Sokolow–Lyon showed the highest specificity (88.4%), with substantially overlapping CIs across criteria. ECG may serve as a practical first-line screening tool, but its modest accuracy does not permit definitive diagnosis or exclusion of LVH; echocardiography remains required for confirmation and assessment of left ventricular geometry.
No takes yet. Share an insight, caveat, or question.
Lilycia Elisabeth Limbong (2026) conducted a cross-sectional in Uncomplicated hypertension (n=150). Electrocardiographic LVH criteria (Cornell Product, Sokolow-Lyon, Romhilt-Estes, and Peguero-Lo Presti) vs. Transthoracic echocardiography (American Society of Echocardiography recommendations) was evaluated on Diagnostic accuracy for echocardiographic left ventricular hypertrophy (sensitivity, specificity, predictive values, and ROC AUC) (AUC 0.680 (Peguero-Lo Presti), 95% CI 0.566-0.793, p=<0.001 (Romhilt-Estes); 0.023 (Sokolow-Lyon)). ECG criteria for LVH showed low sensitivity and high specificity, with Peguero-Lo Presti achieving the highest discrimination.
Synapse has enriched 10 related papers. Consider them for comparative context: